BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 33104026)

  • 21. Role of β-Amyloidosis and Neurodegeneration in Subsequent Imaging Changes in Mild Cognitive Impairment.
    Knopman DS; Jack CR; Lundt ES; Wiste HJ; Weigand SD; Vemuri P; Lowe VJ; Kantarci K; Gunter JL; Senjem ML; Mielke MM; Machulda MM; Roberts RO; Boeve BF; Jones DT; Petersen RC
    JAMA Neurol; 2015 Dec; 72(12):1475-83. PubMed ID: 26437123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alzheimer Disease Signature Neurodegeneration and APOE Genotype in Mild Cognitive Impairment With Suspected Non-Alzheimer Disease Pathophysiology.
    Schreiber S; Schreiber F; Lockhart SN; Horng A; Bejanin A; Landau SM; Jagust WJ;
    JAMA Neurol; 2017 Jun; 74(6):650-659. PubMed ID: 28319241
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlations between atrophy of the entorhinal cortex and cognitive function in patients with Alzheimer's disease and mild cognitive impairment.
    Li X; Jiao J; Shimizu S; Jibiki I; Watanabe K; Kubota T
    Psychiatry Clin Neurosci; 2012 Dec; 66(7):587-93. PubMed ID: 23252925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 18F-FDG Is a Superior Indicator of Cognitive Performance Compared to 18F-Florbetapir in Alzheimer's Disease and Mild Cognitive Impairment Evaluation: A Global Quantitative Analysis.
    Khosravi M; Peter J; Wintering NA; Serruya M; Shamchi SP; Werner TJ; Alavi A; Newberg AB
    J Alzheimers Dis; 2019; 70(4):1197-1207. PubMed ID: 31322568
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural Brain Volume Covariance Associated with Gait Speed in Patients with Amnestic and Non-Amnestic Mild Cognitive Impairment: A Double Dissociation.
    Allali G; Montembeault M; Saj A; Wong CH; Cooper-Brown LA; Bherer L; Beauchet O
    J Alzheimers Dis; 2019; 71(s1):S29-S39. PubMed ID: 31127784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mapping 3-year changes in gray matter and metabolism in Aβ-positive nondemented subjects.
    Araque Caballero MÁ; Brendel M; Delker A; Ren J; Rominger A; Bartenstein P; Dichgans M; Weiner MW; Ewers M;
    Neurobiol Aging; 2015 Nov; 36(11):2913-2924. PubMed ID: 26476234
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The combination of apolipoprotein E4, age and Alzheimer's Disease Assessment Scale - Cognitive Subscale improves the prediction of amyloid positron emission tomography status in clinically diagnosed mild cognitive impairment.
    Ba M; Ng KP; Gao X; Kong M; Guan L; Yu L;
    Eur J Neurol; 2019 May; 26(5):733-e53. PubMed ID: 30561868
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced FDG-PET brain metabolism and executive function predict clinical progression in elderly healthy subjects.
    Ewers M; Brendel M; Rizk-Jackson A; Rominger A; Bartenstein P; Schuff N; Weiner MW;
    Neuroimage Clin; 2014; 4():45-52. PubMed ID: 24286024
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sex modulates the ApoE ε4 effect on brain tau deposition measured by
    Liu M; Paranjpe MD; Zhou X; Duy PQ; Goyal MS; Benzinger TLS; Lu J; Wang R; Zhou Y
    Theranostics; 2019; 9(17):4959-4970. PubMed ID: 31410194
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Value of FDG-PET scans of non-demented patients in predicting rates of future cognitive and functional decline.
    Torosyan N; Mason K; Dahlbom M; Silverman DHS;
    Eur J Nucl Med Mol Imaging; 2017 Aug; 44(8):1355-1363. PubMed ID: 28331953
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Arterial spin labeling versus
    Dolui S; Li Z; Nasrallah IM; Detre JA; Wolk DA
    Neuroimage Clin; 2020; 25():102146. PubMed ID: 31931403
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Utility of Molecular and Structural Brain Imaging to Predict Progression from Mild Cognitive Impairment to Dementia.
    Lan MJ; Ogden RT; Kumar D; Stern Y; Parsey RV; Pelton GH; Rubin-Falcone H; Pradhaban G; Zanderigo F; Miller JM; Mann JJ; Devanand DP
    J Alzheimers Dis; 2017; 60(3):939-947. PubMed ID: 28984586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Real-world navigation in amnestic mild cognitive impairment: The relation to visuospatial memory and volume of hippocampal subregions.
    Peter J; Sandkamp R; Minkova L; Schumacher LV; Kaller CP; Abdulkadir A; Klöppel S
    Neuropsychologia; 2018 Jan; 109():86-94. PubMed ID: 29237555
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.
    Kunst J; Marecek R; Klobusiakova P; Balazova Z; Anderkova L; Nemcova-Elfmarkova N; Rektorova I
    Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between white matter hyperintensity load and grey matter atrophy in mild cognitive impairment is not unidirectional.
    Vipin A; Wong BYX; Kumar D; Low A; Ng KP; Kandiah N
    Aging (Albany NY); 2021 Apr; 13(8):10973-10988. PubMed ID: 33861727
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anosognosia Is an Independent Predictor of Conversion From Mild Cognitive Impairment to Alzheimer's Disease and Is Associated With Reduced Brain Metabolism.
    Gerretsen P; Chung JK; Shah P; Plitman E; Iwata Y; Caravaggio F; Nakajima S; Pollock BG; Graff-Guerrero A;
    J Clin Psychiatry; 2017; 78(9):e1187-e1196. PubMed ID: 29022655
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of Aerobic Training on Cognition and Brain Glucose Metabolism in Subjects with Mild Cognitive Impairment.
    Porto FH; Coutinho AM; Pinto AL; Gualano B; Duran FL; Prando S; Ono CR; Spíndola L; de Oliveira MO; do Vale PH; Nitrini R; Buchpiguel CA; Brucki SM
    J Alzheimers Dis; 2015; 46(3):747-60. PubMed ID: 25835427
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alzheimer Disease and Mild Cognitive Impairment: Integrated Pulsed Arterial Spin-Labeling MRI and
    Riederer I; Bohn KP; Preibisch C; Wiedemann E; Zimmer C; Alexopoulos P; Förster S
    Radiology; 2018 Jul; 288(1):198-206. PubMed ID: 29762090
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Associations of rest-activity patterns with amyloid burden, medial temporal lobe atrophy, and cognitive impairment.
    Roh HW; Choi JG; Kim NR; Choe YS; Choi JW; Cho SM; Seo SW; Park B; Hong CH; Yoon D; Son SJ; Kim EY
    EBioMedicine; 2020 Aug; 58():102881. PubMed ID: 32736306
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cognitive Correlates of Basal Forebrain Atrophy and Associated Cortical Hypometabolism in Mild Cognitive Impairment.
    Grothe MJ; Heinsen H; Amaro E; Grinberg LT; Teipel SJ
    Cereb Cortex; 2016 Jun; 26(6):2411-2426. PubMed ID: 25840425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.